DERM - Journey Medical Corp - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DERM is currently covered by 3 analysts with an average price target of $12.29. This is a potential upside of $5 (68.59%) from yesterday's end of day stock price of $7.29.

Journey Medical Corp's activity chart (see below) currently has 13 price targets and 13 ratings on display. The stock rating distribution of DERM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 26.79% with an average time for these price targets to be met of 175.5 days.

Highest price target for DERM is $13, Lowest price target is $12, average price target is $12.67.

Most recent stock forecast was given by BRANDON FOLKES from HC WAINWRIGHT on 25-Aug-2025. First documented stock forecast 07-Dec-2021.

Best performing analysts who are covering DERM - Journey Medical Corp:

Kalpit Patel Scott Henry Brandon Folkes Thomas Flaten

Currently out of the existing stock ratings of DERM, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$5.67 (77.35%)

$9

1 months 12 days ago
(25-Aug-2025)

0/2 (0%)

$5.6 (75.68%)

Buy

$13

$5.67 (77.35%)

$9

1 months 24 days ago
(13-Aug-2025)

0/2 (0%)

$5.75 (79.31%)

Buy

$12

$4.67 (63.71%)

$6

2 months 7 days ago
(30-Jul-2025)

4/7 (57.14%)

$4.41 (58.10%)

159

Buy

$8.5

$1.17 (15.96%)

$15

1 years 7 months 21 days ago
(16-Feb-2024)

1/2 (50%)

$4.24 (99.53%)

543

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is DERM (Journey Medical Corp) average time for price targets to be met?

On average it took 175.5 days on average for the stock forecasts to be realized with a an average price target met ratio 26.79

Which analyst has the current highest performing score on DERM (Journey Medical Corp) with a proven track record?

KALPIT PATEL

Which analyst has the current lower performing score on DERM (Journey Medical Corp) with a proven track record?

THOMAS FLATEN

Which analyst has the most public recommendations on DERM (Journey Medical Corp)?

Kalpit Patel works at B. RILEY and has 3 price targets and 2 ratings on DERM

Which analyst is the currently most bullish on DERM (Journey Medical Corp)?

Thomas Flaten with highest potential upside - $5.67

Which analyst is the currently most reserved on DERM (Journey Medical Corp)?

Scott Henry with lowest potential downside - $1.17

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?